Trials / Unknown
UnknownNCT00370539
Combined PDT and Intravitreal Bevacizumab vs Combination of PDT, Intravitreal Bevacizumab and Triamcinolone for Neovascular AMD
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Shahid Beheshti University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
To compare the efficacy and safety of photodynamic therapy (PDT) combined with intravitreal bevacizumab versus combination of photodynamic therapy , intravitreal bevacizumab and intravitreal triamcinolone for neovascular AMD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | verteporfin, bevacizumab, triamcinolone acetonide |
Timeline
- Start date
- 2006-09-01
- Completion
- 2006-11-01
- First posted
- 2006-08-31
- Last updated
- 2006-11-14
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT00370539. Inclusion in this directory is not an endorsement.